Infertility/ART/IVF

FRIDAY, NOVEMBER 20

09:00-10:30 FAILURE OF IVF – WHAT TO CHECK, WHAT TO TRY
Hall I
Capsule
Chairpersons Rene Frydman, France
Georg Griesinger, Germany
09:00-09:20 Mitochondria and oocyte aging
Juan Antonio Garcia Velasco, Spain
09:20-10:05 Debate: Duo-stimulation
Pro: Filippo Maria Ubaldi, Italy

Con: Bart Fauser, Netherlands
Discussion
10:05-10:30 The effect of ovarian stimulation on embryo ploidy status
Willem Verpoest, Belgium
10:30-11:00 VIRTUAL EXHIBITION AND E-POSTER VIEWING
EXHIBITION AND E-POSTER HALL
11:00-12:30 DIAGNOSTIC PROCEDURE
Hall I
Capsule  
Chairperson  Ben Mol, Australia
11:00-11:20 Fertility enhancement using oil-and-water-based contrast media with ultrasound guidance
Emmeline Lee, Australia
11:20-11:40 Tubal flushing with oil-based contrast should be offered to every infertile couple
Ben Mol, Australia
11:40-11:55 How far should we evaluate the couple genetic risk?
Rita Vassena, Spain
11:55-12:10 Unexplained infertility: What do we do?
Fulco van der Veen, Netherlands
12:10-12:30 Special countercurrent lecture: The microbiome at ART
Joop Laven, Netherlands
12:30-15:05 VIRTUAL EXHIBITION, E-POSTER VIEWING AND EARLY AFTERNOON SESSIONS
VARIOUS HALLS
12:30-13:30 INDUSTRY SUPPORTED SESSION
Hall I
14:00-14:05 BREAK
14:05-15:05 ISMAAR SESSION: THE ROLE OF ULTRASOUND IN IVF PROGRAM
Hall I
Capsule
Chairperson Rene Frydman, France
14:05-14:35 The role of advanced ultrasound to optimise IVF outcomes
Stuart Campbell, UK
14:35-15:05 How targeted ultrasound can help reduce complications and hospital admissions in the post COVID era
Geeta Nargund, UK
15:05-15:10 BREAK
15:10-16:40 PROGESTERONE AND ESTROGENS: WHAT TO KNOW FOR PMA FOR OPTIMIZING RESULTS
A PREIS SCHOOL ACADEMY SESSION

Hall I
Capsule  
Chairperson Rene Frydman, France
Gian Carlo Di Renzo, Italy
15:10-15:15 Introduction
Gian Carlo Di Renzo
, Italy
15:15-15:35 Pharmacodynamics: What to know
Paul Piette, Belgium
15:35-15:55 Progesterone in fetal and neonatal brain protection
Michael Schumacher, France
15:55-16:15 Luteal phase support
Elena Labarta, Spain
16:15-16:35 Choice of protocols for progestogen usage in threatened miscarriage and recurrent pregnancy loss
Klaus Diedrich, Germany 
16:35-16:40 Discussion / Q&A
16:40-17:00 VIRTUAL EXHIBITION AND E-POSTER VIEWING
EXHIBITION AND E-POSTER HALL
17:00-18:30 ADVANCED SOLUTIONS TO IMPROVE FERTILITY Hall I
Capsule
Chairpersons Edgardo Somigliana, Italy
17:00-17:20 Kiss-peptin: Promise becomes the standard?
Cornelis B. Lambalk, Netherlands
17:20-17:40 Meiosis gene dysfunction as a cause in infertility
Willem Verpoest, Belgium
17:40-18:00 Poor sperm quality: There’s more than just a fertility problem
Michael Eisenberg, USA
18:00-18:30 Debate: Cesarean scar defect: When residual myometrial thickness is less than 3mm
Pro hysteroscopy: Sylvia Mechsner, Germany
Pro laparoscopy: Olivier Donnez, Belgium
Discussion

SATURDAY, NOVEMBER 21

09:00-10:30 RESEARCH
Hall I
Capsule Much of the published medical research is apparently flawed, cannot be replicated and or has a limited or no utility (Altman 1994)
Chairpersons TBA
09:00-09:20 Are we neglecting scientific fraud?
Ben Mol, Australia
09:20-09:40 Big data is important way forward in medical research. How can big data supplement RCT’s?
Bart Fauser, Netherlands
09:40-10:05 Repeated Implantation Failure (RIF): A misleading non-standardized definition that affects the quality of publication
Zion Ben Rafael, Israel
10:05-10:30 RCT’s have a central role in medical research
Ben Mol, Australia
10:30-11:00 VIRTUAL EXHIBITION AND E-POSTER VIEWING
EXHIBITION AND E-POSTER HALL
11:00-12:30 ADD-ONS LABORATORIES AND CLINICAL PROCEDURES
Hall I
Chairpersons Laura Rienzi, Italy
Zion Ben Rafael
, Israel
Bart Fauser, Netherlands
Discussants Simon Fishel, UK
Rita Vassena, Spain
Georg Griesinger, Germany
Ben Mol, Australia
Joop Laven
, Netherlands
Lab procedures RTD
  • Artificial egg activation calcium ionophore
  • Intracytoplasmic morphologic sperm injection (IMSI) and physiological intracytoplasmic sperm injection (PICSI): Where is the proof?
  • Perfect timings in the embryology lab: When to denude, when to fertilize, when to culture?
  • The automated IVF lab of the future
  • Microfluidics for sperm selection, does it work? What benefits can we see from the clinical point of view?
  • What is the optimal culture media?
  • Noninvasive embryo selection
Clinical procedures RTD
  • Any value to reproductive immunology tests and treatments?
  • Embryo glue?
  • Recurrent implantation failure does not exist!
  • IUI deserves a place in the treatment of unexplained infertility
  • What are the clinical risks of freeze all?
12:30-15:05 VIRTUAL EXHIBITION, E-POSTER VIEWING AND EARLY AFTERNOON SESSIONS
VARIOUS HALLS
12:30-14:00 WORKSHOP ON UNDERSTANDING CURRENT ADD-ONS
Hall I
Capsule Up to 74% of UK patients attending IVF received some sort of add-ons: none of which received the HFEA green “go ahead” light.
Add-ons are expensive, sophisticated, time consuming and widely used, with the false pretext of providing better results. A summary of the situation was given 25 years ago: “much poor research arises because researchers feel compelled for career reasons to carry out research that they are ill equipped to performed and nobody stops them” (Altman DG, BMJ, 1994)
Chairperson Zion Ben Rafael¸ Israel
12:30-12:50 End of endometrial scratching?
Ben Mol, Australia
12:50-13:10 ERA test – What are the reservations?
Zion Ben Rafael, Israel
13:10-13:30 Non-invasive PGD-A is the future!
Samir Hamamah, France
13:30-14:00 Debate: End of freeze all?
Yes – Freeze all should be used carefully and by indication Abha Maheshwari, UK
No – Freeze all serves to circumvent faulty endometrium Bruce S. Shapiro, USA
Discussion
14:00-14:05 BREAK
14:05-15:05 INDUSTRY SUPPORTED SESSION Hall I
15:05-15:10 BREAK
15:10-16:40 PGT-A: HELPFUL OR HARMFUL
Hall I
Capsule HFEA recently downgraded PGT-A from “Amber” to “Red”, suggesting it has no proofs, are we all in agreement?
Chairpersons Simon Fishel, UK
Luca Gianaroli, Italy
15:10-15:40 Debate: What happens after the STAR and ESTEEM studies trials that have failed to show better results? Should we stop proposing PGT-A to patients? Should we change out clinical attitude towards the test?
No: Willem Verpoest, Belgium
Yes:  Sebastiaan Mastenbroek, Netherlands
Discussion
15:40-16:10 Debate: There are now studies indicating that up to 50% of 1PN embryos are normal. Should we discard them?
Yes: Tina Buchholz, Germany
No: Rita Vassena, Spain
Discussion
16:10-16:40 Special countercurrent lecture: Technology versus biology, how biology presents a limitation to PGT-A
Rajiv McCoy, USA
16:40-17:00 VIRTUAL EXHIBITION AND E-POSTER VIEWING
EXHIBITION AND E-POSTER HALL
17:00-18:30 PCOS
Hall I
Capsule
Chairperson  Bart FauserNetherlands
17:00-17:25 New aspects of the polycystic ovary syndrome
Joop Laven, Netherlands
17:25-17:45 AMH and its role in the pathophysiology of PCOS
Antonio La Marca, Italy
17:45-18:10 Implications of Cardiometabolic dysfunction in PCOS women
Bart Fauser, Netherlands
18:10-18:30 Effects of a three-component lifestyle program on weight loss in women with PCOS
Geranne Jiskoot, Netherlands